Derek W Ebner
Overview
Explore the profile of Derek W Ebner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greene M, Pew T, Dore M, Ebner D, Ozbay A, Johnson W, et al.
Int J Colorectal Dis
. 2025 Feb;
40(1):48.
PMID: 39992481
Purpose: Adherence to colorectal cancer (CRC) re-screening is essential to maximize screening effectiveness. This study assessed adherence to a multi-target stool DNA (mt-sDNA) test among previous users in the USA...
2.
Phillips H, Fetzer J, Bhattarai S, Perneth S, Codipilly D, Codipilly D, et al.
Gastrointest Endosc
. 2025 Jan;
PMID: 39832556
Background And Aims: An irregular Z-line is characterized by a squamocolumnar junction (SCJ) that extends proximally above the gastroesophageal junction by <1 cm, whereas Barrett's esophagus is defined as a...
3.
Le Q, Kiener T, Johnson H, Li K, Limburg P, Fendrick A, et al.
Prev Med
. 2024 Dec;
191():108213.
PMID: 39724976
Introduction: Blood-based tests represent a compelling option for early detection and management of cancers and other chronic diseases. While they may increase patient engagement, assumptions about greater adherence in clinical...
4.
Kisiel J, Fendrick A, Ebner D, Ozbay A, Vahdat V, Estes C, et al.
J Med Econ
. 2024 Apr;
27(1):746-753.
PMID: 38686394
Objective: This analysis estimated the outcomes of triennial blood-based colorectal cancer (CRC) screening at various adherence, including perfect adherence, compared with triennial multi-target stool DNA (mt-sDNA) screening at the reported...
5.
Ebner D, Finney Rutten L, Miller-Wilson L, Markwat N, Vahdat V, Ozbay A, et al.
Cancer Prev Res (Phila)
. 2024 Apr;
17(6):275-280.
PMID: 38561018
Prevention Relevance: This retrospective study highlights the importance of convenient stool-based colorectal cancer screening options to achieve the national goal of 80% for overall colorectal cancer screening rates. Empowering screening-eligible...
6.
Ebner D, Kisiel J, Fendrick A, Estes C, Li K, Vahdat V, et al.
JAMA Netw Open
. 2024 Mar;
7(3):e245537.
PMID: 38551567
No abstract available.
7.
Fendrick A, Kisiel J, Brooks D, Vahdat V, Estes C, Ebner D, et al.
Popul Health Manag
. 2023 Nov;
26(6):448-450.
PMID: 37930304
No abstract available.
8.
Ebner D, Burger K, Broderick B, Mahoney D, Kellogg T, Acosta A, et al.
Gastro Hep Adv
. 2023 Oct;
2(7):902-910.
PMID: 37876832
Background And Aims: Bariatric and metabolic surgery (BMS) may adversely affect noninvasive stool tests for colorectal cancer (CRC) screening through several mechanisms. Multitarget stool DNA (mt-sDNA) is approved for CRC...
9.
Ebner D, Rushlow D, Mou J, Porter K, Finney Rutten L, Limburg P, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2023 Jul;
7(4):320-326.
PMID: 37502338
Objective: To evaluate the effect of hemorrhoids on noninvasive stool test performance for colorectal cancer (CRC) screening. Patients And Methods: We conducted a retrospective cohort study of test characteristics for...
10.
Ebner D, Burger K, Mahoney D, Broderick B, Eckmann J, Devens M, et al.
Dig Dis Sci
. 2023 Jul;
68(9):3721-3731.
PMID: 37486445
Background And Aims: Variation in colorectal neoplasia detection limits the effectiveness of screening colonoscopy. By evaluating neoplasia detection rates of individual colonoscopists, we aimed to quantify the effects of pre-procedural...